Literature DB >> 15885458

Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.

S P Vyas1, R P Singh, Sanyog Jain, Vivek Mishra, Sunil Mahor, Paramjit Singh, P N Gupta, A Rawat, P Dubey.   

Abstract

DNA vaccines are capable of eliciting both humoral as well as cellular immune responses. Liposomes have been widely employed for DNA delivery through topical route; however, they suffer from certain drawbacks like higher cost and instability. In present study, non-ionic surfactant based vesicles (niosomes) for topical DNA delivery have been developed. DNA encoding hepatitis B surface antigen (HBsAg) was encapsulated in niosomes. Niosomes composed of span 85 and cholesterol as constitutive lipids were prepared by reverse phase evaporation method. Prepared niosomes were characterized for their size, shape and entrapment efficiency. The immune stimulating activity was studied by measuring serum anti-HBsAg titer and cyokines level (IL-2 and IFN-gamma) following topical application of niosomes in Balb/c mice and results were compared with naked DNA and liposomes encapsulated DNA applied topically as well as naked DNA and pure recombinant HBsAg administered intramuscularly. It was observed that topical niosomes elicited a comparable serum antibody titer and endogenous cytokines levels as compared to intramuscular recombinant HBsAg and topical liposomes. The study signifies the potential of niosomes as DNA vaccine carriers for effective topical immunization. The proposed system is simple, stable and cost effective compared to liposomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885458     DOI: 10.1016/j.ijpharm.2005.02.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

Review 1.  Topical vaccination: the skin as a unique portal to adaptive immune responses.

Authors:  Chun-Ming Huang
Journal:  Semin Immunopathol       Date:  2007-04       Impact factor: 9.623

2.  Nonionic surfactant vesicles composed of novel spermine-derivative cationic lipids as an effective gene carrier in vitro.

Authors:  Orapan Paecharoenchai; Nattisa Niyomtham; Lalita Leksantikul; Tanasait Ngawhirunpat; Theerasak Rojanarata; Boon-ek Yingyongnarongkul; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2014-03-13       Impact factor: 3.246

3.  Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate.

Authors:  Sanyog Jain; Bankim H Chaudhari; Nitin K Swarnakar
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

5.  Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.

Authors:  Chandan Thomas; Vivek Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

6.  Nonionic surfactant vesicles for delivery of RNAi therapeutics.

Authors:  Orapan Paecharoenchai; Lesheng Teng; Bryant C Yung; Lirong Teng; Praneet Opanasopit; Robert J Lee
Journal:  Nanomedicine (Lond)       Date:  2013-11       Impact factor: 5.307

Review 7.  Progress towards a needle-free hepatitis B vaccine.

Authors:  Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

8.  PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.

Authors:  Yongzhuo Huang; Jinliang Chen; Xiaojin Chen; Jianqing Gao; Wenquan Liang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

9.  Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.

Authors:  Meng Zhong; Yue Feng; Hong Liao; Xueyuan Hu; Shengli Wan; Biyue Zhu; Mi Zhang; Huarong Xiong; Yunli Zhou; Jingqing Zhang
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

10.  Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin.

Authors:  Loree C Heller; Mark J Jaroszeski; Domenico Coppola; Richard Heller
Journal:  Genet Vaccines Ther       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.